Abstract:ID 98732 Poster Board 486 Addiction to tobacco and nicotine products remains a leading cause of disease and death worldwide, and an increasing number of never-smokers are being exposed to nicotine via e-cigarettes. With only a few moderately efficacious smoking-cessation therapeutics available, achieving long-term abstinence from nicotine addiction is an unattainable goal for millions. The role of brain nicotinic acetylcholine receptors (nAChRs) in nicotine's behavioral effects leading to tobacco addiction is well recognized. However, the neurobiological basis underlying the role of specific nAChRs in nicotine's behavioral effects remains poorly understood. Our recently published findings have emphasized the role of the high-sensitivity isoform of the α4β2 nAChRs (the HS (α4)2(β2)3 nAChR) in nicotine-associated behavior. Therefore, our current efforts are focused on the development of novel positive allosteric modulators (PAMs) that selectively target the HS (α4)2(β2)3 nAChR for in vivo applications to probe the function of this major nAChR subtype as well as for potential therapeutic applications as smoke-cessation aid. Unlike classical nAChR agonists, which bind at the evolutionary conserved ACh binding site, PAMs bind to sites that are less conserved and potentially unique to the HS (α4)2(β2)3 nAChR making the subtype selectively more attenable. In addition, PAMs act only in the presence of the endogenous neurotransmitter, minimizing tonic activation, desensitization, receptor upregulation, and alteration in the pattern of cholinergic synaptic transmission seen with nAChR agonists. Using three nAChR PAM pharmacophores and computational ligand docking predictions, we synthesized a series of derivatives and examined their nAChR PAM activities (ability to enhance ACh-induced current responses) in vitro . Candidates with potent and efficacious in vitro HS (α4)2(β2)3 nAChR PAM activities are currently being evaluated for their ability to reduce nicotine self-intake and withdrawal symptoms in mice.

Partial Agonists for Α4β2 Nicotinic Receptors Stimulate Dopaminergic Neuron Firing with Relatively Enhanced Maximal Effects

Chronic Nicotine Cell Specifically Upregulates Functional Α4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path

The Subtype-Selective Nicotinic Acetylcholine Receptor Positive Allosteric Potentiator 2087101 Differentially Facilitates Neurotransmission in the Brain.

Roles Of Nicotinic Acetylcholine Receptor Beta Subunits In Function Of Human Alpha 4-Containing Nicotinic Receptors

Optimizing positive allosteric modulators to selectively target the high sensitivity 23 nicotinic acetylcholine receptor

Nicotine Dynamically Modulates Dopamine Clearance in Rat Striatum in Vivo

Partial Activation of Α7 Nicotinic Acetylcholine Receptors: Insights from Molecular Dynamics Simulations.

Increases in Alpha 4but Not Alpha 3/alpha 6*nicotinic Receptor Sites and Function in the Primate Striatum Following Chronic Oral Nicotine Treatment

Differential Regulation of Mesolimbic Α3/α6β2 and Α4β2 Nicotinic Acetylcholine Receptor Sites and Function after Long-Term Oral Nicotine to Monkeys

The Sensitizing Effect of Acute Nicotine on Amphetamine-Stimulated Behavior and Dopamine Efflux Requires Activation of Β2 Subunit-Containing Nicotinic Acetylcholine Receptors and Glutamate N-methyl-d-aspartate Receptors

Blocking Alpha(4)Beta(2) And Alpha(7) Nicotinic Acetylcholine Receptors Inhibits The Reinstatement Of Morphine-Induced Cpp By Drug Priming In Mice

The nicotinic α4β2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices

Modulation of dopamine release in the striatum by physiologically relevant levels of nicotine

A Concurrent Excitation and Inhibition of Dopaminergic Subpopulations in Response to Nicotine

SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats

Reversal of a Vigilance Decrement in the Aged Rat by Subtype-Selective Nicotinic Ligands

Synthesis and Biological Evaluation of Novel Hybrids of Highly Potent and Selective Α4β2-Nicotinic Acetylcholine Receptor (nachr) Partial Agonists.

Highly selective and potent α4β2 nAChR antagonist inhibits nicotine self-administration and reinstatement in rats.

Long-Term Nicotine Treatment Decreases Striatal Alpha 6 Nicotinic Acetylcholine Receptor Sites And Function In Mice

Partial Recovery of Striatal Nicotinic Receptors in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Mptp)-Lesioned Monkeys with Chronic Oral Nicotine.

Characterization of Gα and Gα activation by catechol and non-catechol dopamine D1 receptor agonists